Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Melanoma Research|November 9, 2020
Anti-programmed cell death-1 therapy in octogenarian and nonagenarian advanced/metastatic melanoma patientsBożena Cybulska-Stopa, Marcin Ziętek, Grażyna Kamińska-Winciorek, et al.
Targeted Oncology|June 24, 2025
Discontinuation of Immune Checkpoint Inhibition in Patients with Advanced Unresectable Melanoma Achieving CR, PR, or SDAnna M Czarnecka, Paweł Teterycz, Krzysztof Ostaszewski, et al.
Targeted Oncology|March 11, 2023
Long-Term Real-World Outcomes and Safety of Vemurafenib and Vemurafenib + Cobimetinib Therapy in Patients with BRAF-Mutated MelanomaKarolina Piejko, Bożena Cybulska-Stopa, Marcin Ziętek, et al.
The Journal of Dermatological Treatment|May 31, 2021
Development of immunity-related adverse events correlates with baseline clinical factors, survival and response to anti-PD-1 treatment in patients with inoperable or metastatic melanomaBożena Cybulska-Stopa, Marcin Ziętek, Anna M Czarnecka, et al.
Melanoma Research|April 4, 2023
Long-term clinical evidence of comparable efficacy and toxicity of nivolumab and pembrolizumab in advanced melanoma treatmentBożena Cybulska-Stopa, Karolina Piejko, Krzysztof Ostaszewski, et al.
Cancers|May 14, 2022
Long Term Results and Prognostic Biomarkers for Anti-PD1 Immunotherapy Used after BRAFi/MEKi Combination in Advanced Cutaneous Melanoma PatientsPaweł Rogala, Anna M Czarnecka, Bożena Cybulska-Stopa, et al.
Scientific Reports|May 31, 2024
Pulsed electric field induces exocytosis and overexpression of MAGE antigens in melanomaWojciech Szlasa, Natalia Sauer, Dagmara Baczyńska, et al.
Cancers|June 22, 2023
The Current Treatment Trends and Survival Patterns in Melanoma Patients with Positive Sentinel Lymph Node Biopsy (SLNB): A Multicenter Nationwide StudyMarcin Ziętek, Paweł Teterycz, Jędrzej Wierzbicki, et al.
Journal of Clinical Medicine|April 23, 2022
Long-Term Outcomes of Targeted Therapy after First-Line Immunotherapy in BRAF-Mutated Advanced Cutaneous Melanoma Patients-Real-World EvidencePaweł Rogala, Anna M Czarnecka, Bożena Cybulska-Stopa, et al.
Immunotherapy|December 23, 2020
First-line treatment of advanced/metastatic melanoma with anti-PD-1 antibodies: multicenter experience in PolandBożena Cybulska-Stopa, Renata Pacholczak-Madej, Grażyna Kamińska-Winciorek, et al.
Pageof 5